First Patient Dosed With Lixte’s Lb-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating With Nki, Supported by Major Pharma Company
首位患者接受了Lixte研發的Lb-100進行治療結直腸癌的新臨床試驗,與Nki合作,得到了一家大型製藥公司的支持。
First Patient Dosed With Lixte’s Lb-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating With Nki, Supported by Major Pharma Company
首位患者接受了Lixte研發的Lb-100進行治療結直腸癌的新臨床試驗,與Nki合作,得到了一家大型製藥公司的支持。
譯文內容由第三人軟體翻譯。